Modification of LDL with human secretory phospholipase A2 or sphingomyelinase promotes its arachidonic acid-releasing propensity

This publication has 32 references indexed in Scilit:

• Lipolysis of LDL by Human Secretory Phospholipase A ₂ Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo : A possible link between inflammatory cytokines and atherogenesis
  Proceedings of the National Academy of Sciences, 2000
• Enzymatically Degraded, Nonoxidized LDL Induces Human Vascular Smooth Muscle Cell Activation, Foam Cell Transformation, and Proliferation
  Circulation, 2000
• Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Circulating Levels of Secretory Type II Phospholipase A ₂ Predict Coronary Events in Patients with Coronary Artery Disease
  Circulation, 1999
• Role of Group II Secretory Phospholipase A ₂ in Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Atherosclerosis — An Inflammatory Disease
  New England Journal of Medicine, 1999
• Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2 Only Aggregation, of Low Density Lipoprotein (LDL) Particles
  Journal of Biological Chemistry, 1998
• Localization of Nonpancreatic Secretory Phospholipase A ₂ in Normal and Atherosclerotic Arteries
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Phospholipase A2-modified LDL is taken up at enhanced rate by macrophages
  Biochemical and Biophysical Research Communications, 1992